ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 160 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,147 | +172.4% | 102,698 | +885.1% | 0.01% | +120.0% |
| Q1 2023 | $421 | -100.0% | 10,425 | -44.2% | 0.01% | -50.0% |
| Q3 2022 | $968,000 | +106.0% | 18,673 | +196.6% | 0.01% | +233.3% |
| Q4 2021 | $470,000 | +39.1% | 6,295 | +5.5% | 0.00% | +50.0% |
| Q3 2021 | $338,000 | -51.4% | 5,965 | -62.3% | 0.00% | -66.7% |
| Q2 2021 | $696,000 | +210.7% | 15,830 | +323.4% | 0.01% | -45.5% |
| Q3 2019 | $224,000 | – | 3,739 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |